-
1
-
-
0027519426
-
Immunogenicity and allergenic potential of animal and human insulins
-
Schernthaner G. Immunogenicity and allergenic potential of animal and human insulins. Diab. Care. 16:(Suppl. 3):1993;155-165.
-
(1993)
Diab. Care
, vol.16
, Issue.SUPPL. 3
, pp. 155-165
-
-
Schernthaner, G.1
-
2
-
-
0025321119
-
Insulin allergy; Re-evaluation after two decades
-
Patterson R., Roberts M., Grammer L.C. Insulin allergy; re-evaluation after two decades. Ann. Allergy. 64:1990;459-462.
-
(1990)
Ann. Allergy
, vol.64
, pp. 459-462
-
-
Patterson, R.1
Roberts, M.2
Grammer, L.C.3
-
3
-
-
0030762838
-
Lispro analog for treatment of generalised allergy to human insulin
-
Kumar D. Lispro analog for treatment of generalised allergy to human insulin. Diab. Care. 20:1997;1357-1359.
-
(1997)
Diab. Care
, vol.20
, pp. 1357-1359
-
-
Kumar, D.1
-
4
-
-
18544404062
-
The insulin analog aspart: A safe alternative in insulin allergy
-
Airaghi L., Lorini M., Tedeschi A. The insulin analog aspart: a safe alternative in insulin allergy. Diab. Care. 24:2001;2000.
-
(2001)
Diab. Care
, vol.24
, pp. 2000
-
-
Airaghi, L.1
Lorini, M.2
Tedeschi, A.3
-
5
-
-
0026698991
-
Altering the association properties of insulin by amino acid replacement
-
Brems D.N., Alter L.A., Beckage M.J., et al. Altering the association properties of insulin by amino acid replacement. Protein Eng. 5:1992;527-533.
-
(1992)
Protein Eng.
, vol.5
, pp. 527-533
-
-
Brems, D.N.1
Alter, L.A.2
Beckage, M.J.3
-
7
-
-
0025078913
-
Monomeric insulins and their experimental and clinical implications
-
Brange J., Owens D.R., Kang S., Volund A. Monomeric insulins and their experimental and clinical implications. Diab. Care. 13:1990;923-954.
-
(1990)
Diab. Care
, vol.13
, pp. 923-954
-
-
Brange, J.1
Owens, D.R.2
Kang, S.3
Volund, A.4
-
8
-
-
0027999491
-
The potential immunogenecity of human insulin and insulin analogues evaluated in a transgene mouse model
-
Ottesen J.L., Nilsson P., Jami J., et al. The potential immunogenecity of human insulin and insulin analogues evaluated in a transgene mouse model. Diabetologia. 37:1994;1178-1185.
-
(1994)
Diabetologia
, vol.37
, pp. 1178-1185
-
-
Ottesen, J.L.1
Nilsson, P.2
Jami, J.3
-
9
-
-
0034910474
-
Localized insulin allergy treated with continuous subcutaneous insulin
-
Pratt E.J., Miles P., Kerr D. Localized insulin allergy treated with continuous subcutaneous insulin. Diab. Med. 18:2001;515-516.
-
(2001)
Diab. Med.
, vol.18
, pp. 515-516
-
-
Pratt, E.J.1
Miles, P.2
Kerr, D.3
-
10
-
-
0035511670
-
Human insulin analog insulin aspart does not cause insulin allergy
-
Yasuda H., Nagata M., Moriyama H., et al. Human insulin analog insulin aspart does not cause insulin allergy. Diab. Care. 24:2001;2008-2009.
-
(2001)
Diab. Care
, vol.24
, pp. 2008-2009
-
-
Yasuda, H.1
Nagata, M.2
Moriyama, H.3
-
11
-
-
0036580827
-
Immune responses to insulin aspart and biphasic insulin aspart in people with type 1 and type 2 diabetes
-
Lindholm A., Jensen L.B., Home P.D., Raskin P., Boehm B.O., Rastam J. Immune responses to insulin aspart and biphasic insulin aspart in people with type 1 and type 2 diabetes. Diab. Care. 25:2002;876-882.
-
(2002)
Diab. Care
, vol.25
, pp. 876-882
-
-
Lindholm, A.1
Jensen, L.B.2
Home, P.D.3
Raskin, P.4
Boehm, B.O.5
Rastam, J.6
-
12
-
-
0020656125
-
Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals
-
Schernthaner G., Borkenstein M., Fink M., Mayr W.R., Menzel J., Schober E. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals. Diab Care. 6:(Suppl. 1):1983;43-48.
-
(1983)
Diab Care
, vol.6
, Issue.SUPPL. 1
, pp. 43-48
-
-
Schernthaner, G.1
Borkenstein, M.2
Fink, M.3
Mayr, W.R.4
Menzel, J.5
Schober, E.6
-
13
-
-
0022532287
-
Use of low-dose continuous corticosteroid infusion to facilitate insulin pump use in local insulin hypersensitivity
-
Grant W., deShazo R.D., Frentz J. Use of low-dose continuous corticosteroid infusion to facilitate insulin pump use in local insulin hypersensitivity. Diab. Care. 9:1986;318-319.
-
(1986)
Diab. Care
, vol.9
, pp. 318-319
-
-
Grant, W.1
DeShazo, R.D.2
Frentz, J.3
-
14
-
-
0031850906
-
Beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone
-
Riddle M.C., Schneider J. Beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone. Diab. Care. 21:1998;1052-1057.
-
(1998)
Diab. Care
, vol.21
, pp. 1052-1057
-
-
Riddle, M.C.1
Schneider, J.2
-
15
-
-
0017195548
-
Structure of insulin in 4-zinc insulin
-
Bentley G., Dodson E., Dodson G., Hodgkin D., Mercola D. Structure of insulin in 4-zinc insulin. Nature. 261:1976;166-168.
-
(1976)
Nature
, vol.261
, pp. 166-168
-
-
Bentley, G.1
Dodson, E.2
Dodson, G.3
Hodgkin, D.4
Mercola, D.5
-
16
-
-
0031977357
-
Atomic force microscopy of crystalline insulins: The influence of sequence variation on crystallization and interfacial structure
-
Yip C.M., Brader M.L., DeFelippis M.R., Ward M.D. Atomic force microscopy of crystalline insulins: the influence of sequence variation on crystallization and interfacial structure. Biophys. J. 74:1998;2199-2209.
-
(1998)
Biophys. J.
, vol.74
, pp. 2199-2209
-
-
Yip, C.M.1
Brader, M.L.2
DeFelippis, M.R.3
Ward, M.D.4
-
17
-
-
0025286235
-
Persistent cutaneous insulin allergy resulting from high-molecular-weight insulin aggregates
-
Ratner R.E., Phillips T.M., Steiner M. Persistent cutaneous insulin allergy resulting from high-molecular-weight insulin aggregates. Diabetes. 39:1990;728-733.
-
(1990)
Diabetes
, vol.39
, pp. 728-733
-
-
Ratner, R.E.1
Phillips, T.M.2
Steiner, M.3
-
18
-
-
0025735460
-
A case of insulin allergy; The crystalline human insulin may mask its antigenicity
-
Takatsuki H., Ishii H., Yamauchi T., et al. A case of insulin allergy; the crystalline human insulin may mask its antigenicity. Diab. Res. Clin. Pract. 12:1991;137-139.
-
(1991)
Diab. Res. Clin. Pract.
, vol.12
, pp. 137-139
-
-
Takatsuki, H.1
Ishii, H.2
Yamauchi, T.3
-
19
-
-
0342657181
-
Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use
-
Kurtzhals P., Schaffer L., Sorensen A., et al. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes. 49:2000;999-1005.
-
(2000)
Diabetes
, vol.49
, pp. 999-1005
-
-
Kurtzhals, P.1
Schaffer, L.2
Sorensen, A.3
-
20
-
-
0018600816
-
Immunoreactivity of insulin antibodies in insulin-treated diabetics: Significance of the beta-chain carboxy-terminal amino acid (B-30) of insulin
-
Kumar D. Immunoreactivity of insulin antibodies in insulin-treated diabetics: significance of the beta-chain carboxy-terminal amino acid (B-30) of insulin. Diabetes. 28:1979;994-1000.
-
(1979)
Diabetes
, vol.28
, pp. 994-1000
-
-
Kumar, D.1
-
21
-
-
0029624346
-
Primary systemic allergy to human insulin; Recurrence of generalized urticaria after successful desensitization
-
Chng H.H., Leong K.P., Loh K.C. Primary systemic allergy to human insulin; recurrence of generalized urticaria after successful desensitization. Allergy. 50:1995;984-987.
-
(1995)
Allergy
, vol.50
, pp. 984-987
-
-
Chng, H.H.1
Leong, K.P.2
Loh, K.C.3
-
22
-
-
0014602845
-
Reaginic antibody against insulin; Demonstration of antigenic distinction between native and extracted insulin
-
Patterson R., Lucena G., Metz R., Roberts M. Reaginic antibody against insulin; demonstration of antigenic distinction between native and extracted insulin. J. Immunol. 103:1969;1061-1071.
-
(1969)
J. Immunol.
, vol.103
, pp. 1061-1071
-
-
Patterson, R.1
Lucena, G.2
Metz, R.3
Roberts, M.4
-
23
-
-
0033197966
-
Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation
-
van Neerven R.J., Wikborg T., Lund G., et al. Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation. J. Immunol. 163:1999;2944-2952.
-
(1999)
J. Immunol.
, vol.163
, pp. 2944-2952
-
-
Van Neerven, R.J.1
Wikborg, T.2
Lund, G.3
-
24
-
-
0023754646
-
CSII in management of insulin allergy
-
Valentini U., Cimino A., Rocca L., Pelizzari R., Rotondi A., Tosoni C. CSII in management of insulin allergy. Diab. Care. 11:1988;97-98.
-
(1988)
Diab. Care
, vol.11
, pp. 97-98
-
-
Valentini, U.1
Cimino, A.2
Rocca, L.3
Pelizzari, R.4
Rotondi, A.5
Tosoni, C.6
-
25
-
-
0030866039
-
Immediate-type human insulin allergy successfully treated by continuous subcutaneous insulin infusion
-
Nagai T., Nagai Y., Tomizawa T., Mori M. Immediate-type human insulin allergy successfully treated by continuous subcutaneous insulin infusion. Intern. Med. 36:1997;575-578.
-
(1997)
Intern. Med.
, vol.36
, pp. 575-578
-
-
Nagai, T.1
Nagai, Y.2
Tomizawa, T.3
Mori, M.4
|